Time response of oxidative/nitrosative stress and inflammation in LPS-induced endotoxaemia—a comparative study of mice and rats

International Journal of Molecular Sciences

Volumn 18, Issue 10, 2017, Pages

  Steven, Sebastian ^a   Dib, Mobin ^a   Roohani, Siyer ^a   Kashani, Fatemeh ^a   Münzel, Thomas ^a   Daiber, Andreas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Endotoxaemia; Inflammation; Mouse; Oxidative stress; Rat; Sepsis; Time response

Indexed keywords

CD11B ANTIGEN; CD68 ANTIGEN; HEMOGLOBIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PADGEM PROTEIN; TATA BINDING PROTEIN RELATED FACTOR; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; ZYMOSAN; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHEMOLUMINESCENCE; COMPARATIVE STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPOPOLYSACCHARIDE-INDUCED ENDOTOXEMIA; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY BURST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; THROMBOCYTE COUNT; WESTERN BLOTTING; ANIMAL; BACTEREMIA; BLOOD; C57BL MOUSE; LEUKOCYTE COUNT; MALE; METABOLISM; PLATELET COUNT; REACTION TIME; SALMONELLOSIS; SPECIES DIFFERENCE; WISTAR RAT;

ANIMALS; BACTEREMIA; HEMOGLOBINS; INTERLEUKIN-6; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; P-SELECTIN; PLATELET COUNT; RATS; RATS, WISTAR; REACTION TIME; SALMONELLA INFECTIONS; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 85032015766     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18102176     Document Type: Article

References (38)

1. Rhodes, A.; Phillips, G.; Beale, R.; Cecconi, M.; Chiche, J.D.; De Backer, D.; Divatia, J.; Du, B.; Evans, L.; Ferrer, R.; et al. The surviving sepsis campaign bundles and outcome: Results from the international multicentre prevalence study on sepsis (the impress study). Intensive Care Med. 2015, 41, 1620–1628.
2. Hall, M.J.; Williams, S.N.; DeFrances, C.J.; Golosinskiy, A. Inpatient care for septicemia or sepsis: A challenge for patients and hospitals. NCHS Data Brief 2011, 62, 1–8.
3. Singer, M.; Deutschman, C.S.; Seymour, C.W.; Shankar-Hari, M.; Annane, D.; Bauer, M.; Bellomo, R.; Bernard, G.R.; Chiche, J.D.; Coopersmith, C.M.; et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016, 315, 801–810.
4. Gotts, J.E.; Matthay, M.A. Sepsis: Pathophysiology and clinical management. BMJ 2016, 353, i1585.
5. Bone, R.C. Sir isaac newton, sepsis, sirs, and cars. Crit. Care Med. 1996, 24, 1125–1128.
6. Takao, K.; Miyakawa, T. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 2015, 112, 1167–1172.
7. Seok, J.; Warren, H.S.; Cuenca, A.G.; Mindrinos, M.N.; Baker, H.V.; Xu, W.; Richards, D.R.; McDonald-Smith, G.P.; Gao, H.; Hennessy, L.; et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 2013, 110, 3507–3512.
8. Kroller-Schon, S.; Knorr, M.; Hausding, M.; Oelze, M.; Schuff, A.; Schell, R.; Sudowe, S.; Scholz, A.; Daub, S.; Karbach, S.; et al. Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition. Cardiovasc. Res. 2012, 96, 140–149.
9. Steven, S.; Munzel, T.; Daiber, A. Exploiting the pleiotropic antioxidant effects of established drugs in cardiovascular disease. Int. J. Mol. Sci. 2015, 16, 18185–18223.
10. Steven, S.; Jurk, K.; Kopp, M.; Kroller-Schon, S.; Mikhed, Y.; Schwierczek, K.; Roohani, S.; Kashani, F.; Oelze, M.; Klein, T.; et al. Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice. Br. J. Pharmacol. 2017, 174, 1620–1632.
11. Steven, S.; Hausding, M.; Kroller-Schon, S.; Mader, M.; Mikhed, Y.; Stamm, P.; Zinssius, E.; Pfeffer, A.; Welschof, P.; Agdauletova, S.; et al. Gliptin and glp-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemia. Basic Res. Cardiol. 2015, 110, 6.
12. Mestas, J.; Hughes, C.C. Of mice and not men: Differences between mouse and human immunology. J. Immunol. 2004, 172, 2731–2738.
13. Petterino, C.; Argentino-Storino, A. Clinical chemistry and haematology historical data in control sprague-dawley rats from pre-clinical toxicity studies. Exp. Toxicol. Pathol. 2006, 57, 213–219.
14. Sellers, R.S.; Clifford, C.B.; Treuting, P.M.; Brayton, C. Immunological variation between inbred laboratory mouse strains: Points to consider in phenotyping genetically immunomodified mice. Vet. Pathol. 2012, 49, 32–43.
15. Stewart, D.; Fulton, W.B.; Wilson, C.; Monitto, C.L.; Paidas, C.N.; Reeves, R.H.; De Maio, A. Genetic contribution to the septic response in a mouse model. Shock 2002, 18, 342–347.
16. Anas, A.A.; Wiersinga, W.J.; de Vos, A.F.; van der Poll, T. Recent insights into the pathogenesis of bacterial sepsis. Neth. J. Med. 2010, 68, 147–152.
17. National Heart, L.; Blood Institute, A.C.T.N.; Truwit, J.D.; Bernard, G.R.; Steingrub, J.; Matthay, M.A.; Liu, K.D.; Albertson, T.E.; Brower, R.G.; Shanholtz, C.; et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N. Engl. J. Med. 2014, 370, 2191–2200.
18. Bachschmid, M.; Ullrich, V. Redox signalling in endothelial cells—Novel mechanisms explaining endothelium function and dysfunction in health, disease and aging. BIF futura 2003, 18, 223–230.
19. Yamaguchi, N.; Jesmin, S.; Zaedi, S.; Shimojo, N.; Maeda, S.; Gando, S.; Koyama, A.; Miyauchi, T. Time-dependent expression of renal vaso-regulatory molecules in lps-induced endotoxemia in rat. Peptides 2006, 27, 2258–2270.
20. Hein, O.V.; Misterek, K.; Tessmann, J.P.; van Dossow, V.; Krimphove, M.; Spies, C. Time course of endothelial damage in septic shock: Prediction of outcome. Crit. Care 2005, 9, R323–R330.
21. Alves, B.E.; Montalvao, S.A.; Aranha, F.J.; Lorand-Metze, I.; De Souza, C.A.; Annichino-Bizzacchi, J.M.; De Paula, E.V. Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: A prospective study. J. Transl. Med. 2011, 9, 23.
22. Lange, M.; Connelly, R.; Traber, D.L.; Hamahata, A.; Nakano, Y.; Esechie, A.; Jonkam, C.; von Borzyskowski, S.; Traber, L.D.; Schmalstieg, F.C.; et al. Time course of nitric oxide synthases, nitrosative stress, and poly(adp ribosylation) in an ovine sepsis model. Crit. Care 2010, 14, R129.
23. Nakae, H.; Endo, S.; Inada, K.; Watanabe, M.; Baba, N.; Yoshida, M. Relationship between leukotriene b4 and prostaglandin i2 in patients with sepsis. Res. Commun. Mol. Pathol. Pharmacol. 1994, 86, 37–42.
24. Yellin, S.A.; Nguyen, D.; Quinn, J.V.; Burchard, K.W.; Crowley, J.P.; Slotman, G.J. Prostacyclin and thromboxane a2 in septic shock: Species differences. Circ. Shock 1986, 20, 291–297.
25. Butler, R.R.; Jr.; Wise, W.C.; Halushka, P.V.; Cook, J.A. Thromboxane and prostacyclin production during septic shock. Adv. Shock Res. 1982, 7, 133–145.
26. Cook, J.A.; Wise, W.C.; Butler, R.R.; Reines, H.D.; Rambo, W.; Halushka, P.V. The potential role of thromboxane and prostacyclin in endotoxic and septic shock. Am. J. Emerg. Med. 1984, 2, 28–37.
27. Schildknecht, S.; Heinz, K.; Daiber, A.; Hamacher, J.; Kavakli, C.; Ullrich, V.; Bachschmid, M. Autocatalytic tyrosine nitration of prostaglandin endoperoxide synthase-2 in lps-stimulated raw 264.7 macrophages. Biochem. Biophys. Res. Commun. 2006, 340, 318–325.
28. August, M.; Wingerter, O.; Oelze, M.; Wenzel, P.; Kleschyov, A.L.; Daiber, A.; Mulsch, A.; Munzel, T.; Tsilimingas, N. Mechanisms underlying dysfunction of carotid arteries in genetically hyperlipidemic rabbits. Nitric Oxide 2006, 15, 241–251.
29. Kessler, P.; Bauersachs, J.; Busse, R.; Schini-Kerth, V.B. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 1746–1755.
30. Holub, M. Thromboembolic complications of sepsis: What is the incidence and pathophysiological mechanisms involved? Thromb. Haemost. 2008, 99, 801–802.
31. Tridente, A.; Clarke, G.M.; Walden, A.; Gordon, A.C.; Hutton, P.; Chiche, J.D.; Holloway, P.A.; Mills, G.H.; Bion, J.; Stuber, F.; et al. Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: Analysis of the genosept cohort. Crit. Care 2015, 19, 210.
32. Hocherl, K.; Schmidt, C.; Kurt, B.; Bucher, M. Activation of the pgi(2)/ip system contributes to the development of circulatory failure in a rat model of endotoxic shock. Hypertension 2008, 52, 330–335.
33. Ku, H.C.; Chen, W.P.; Su, M.J. Glp-1 signaling preserves cardiac function in endotoxemic fischer 344 and dpp4-deficient rats. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 382, 463–474.
34. Pacher, P.; Beckman, J.S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87, 315–424.
35. Szabo, C.; Modis, K. Pathophysiological roles of peroxynitrite in circulatory shock. Shock 2010, 34 (Suppl. S1), 4–14.
36. Daiber, A.; August, M.; Baldus, S.; Wendt, M.; Oelze, M.; Sydow, K.; Kleschyov, A.L.; Munzel, T. Measurement of nad(p)h oxidase-derived superoxide with the luminol analogue l-012. Free Radic. Biol. Med. 2004, 36, 101–111.
37. Wenzel, P.; Schulz, E.; Gori, T.; Ostad, M.A.; Mathner, F.; Schildknecht, S.; Gobel, S.; Oelze, M.; Stalleicken, D.; Warnholtz, A.; et al. Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: Implications for nitrate therapy in humans. J. Pharmacol. Exp. Ther. 2009, 330, 63–71.
38. Hausding, M.; Jurk, K.; Daub, S.; Kroller-Schon, S.; Stein, J.; Schwenk, M.; Oelze, M.; Mikhed, Y.; Kerahrodi, J.G.; Kossmann, S.; et al. Cd40l contributes to angiotensin ii-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction. Basic Res. Cardiol. 2013, 108, 386.